Debomoy K Lahiri Selected Research

Metals

7/2009	Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.
12/2008	Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.
1/2008	Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.
11/2005	Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseases.
8/2004	Metal and inflammatory targets for Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Debomoy K Lahiri Research Topics

Disease

115	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2002
26	Amyloid Plaque 03/2024 - 01/2002
18	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 03/2002
13	Neuroblastoma 12/2019 - 11/2002
11	Inflammation (Inflammations) 01/2024 - 11/2002
10	Parkinson Disease (Parkinson's Disease) 05/2024 - 12/2004
9	Neuroinflammatory Diseases 01/2019 - 12/2004
7	Dementia (Dementias) 03/2024 - 01/2002
7	Stroke (Strokes) 11/2015 - 11/2002
6	Disease Progression 08/2022 - 07/2005
6	Autistic Disorder (Autism) 01/2019 - 06/2006
4	Type 2 Diabetes Mellitus (MODY) 05/2024 - 03/2002
4	Memory Disorders (Memory Loss) 09/2019 - 02/2010
4	Neoplasms (Cancer) 01/2013 - 11/2003
3	Down Syndrome (Down's Syndrome) 03/2024 - 01/2013
3	Cognitive Dysfunction 01/2024 - 07/2009
3	Autism Spectrum Disorder 01/2023 - 12/2014
3	Hypoxia (Hypoxemia) 01/2018 - 12/2004
3	Fragile X Syndrome (Martin Bell Syndrome) 01/2016 - 07/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 02/2014
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2019 - 05/2015
2	Infarction (Infarctions) 11/2015 - 03/2007
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012 - 12/2004
2	Erythema Nodosum 01/2004 - 11/2003
1	Nervous System Diseases (Neurological Disorders) 05/2024
1	Weight Loss (Weight Reduction) 05/2024
1	Obesity 05/2024
1	Frontotemporal Dementia (Semantic Dementia) 05/2024

Drug/Important Bio-Agent (IBA)

56	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2002
43	Amyloid (Amyloid Fibrils)IBA 03/2024 - 05/2004
41	Amyloid beta-PeptidesIBA 01/2017 - 01/2002
35	Peptides (Polypeptides)IBA 03/2024 - 01/2002
12	CytokinesIBA 01/2018 - 01/2004
9	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2020 - 01/2006
7	IronIBA 01/2013 - 11/2002
6	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2024 - 03/2002
6	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 08/2003
6	Messenger RNA (mRNA)IBA 01/2019 - 08/2002
6	phenserineIBA 01/2018 - 12/2004
6	Apolipoproteins E (ApoE)IBA 11/2015 - 01/2004
6	Cholinergic Agents (Cholinergics)IBA 01/2014 - 11/2005
6	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 02/2010 - 10/2002
5	tau Proteins (tau Protein)IBA 12/2021 - 04/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 11/2003
5	ApolipoproteinsIBA 01/2010 - 01/2004
5	MetalsIBA 07/2009 - 08/2004
4	RNA (Ribonucleic Acid)IBA 01/2024 - 08/2002
4	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2012
4	Rivastigmine (Exelon)FDA LinkGeneric 03/2020 - 01/2002
4	EnzymesIBA 02/2014 - 06/2004
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 11/2005
4	VaccinesIBA 06/2013 - 08/2004
4	5' Untranslated Regions (5' UTR)IBA 01/2013 - 08/2002
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2024 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2021 - 01/2002
3	LipopolysaccharidesIBA 01/2018 - 05/2012
3	CholesterolIBA 11/2015 - 08/2004
3	ButyrylcholinesteraseIBA 01/2014 - 01/2002
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2013 - 06/2006
3	Glutamic Acid (Glutamate)FDA Link 07/2012 - 12/2004
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2012 - 01/2010
3	Memantine (Namenda)FDA Link 07/2012 - 01/2010
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 11/2002
3	Cholinesterases (Cholinesterase)IBA 07/2010 - 07/2005
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2010 - 03/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 03/2002
3	CopperIBA 12/2008 - 05/2004
3	AcetylcholinesteraseIBA 07/2007 - 11/2005
3	Neuroprotective AgentsIBA 01/2007 - 11/2002
3	MelatoninIBA 11/2005 - 05/2004
3	Vaccinia virus complement-control proteinIBA 12/2004 - 11/2002
2	Insulin (Novolin)FDA Link 05/2024 - 03/2002
2	GlucocorticoidsIBA 01/2018 - 01/2018
2	Amyloidogenic ProteinsIBA 01/2015 - 02/2005
2	Acamprosate (Campral)FDA Link 12/2014 - 07/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2014 - 01/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014 - 11/2005
2	Clioquinol (Vioform)FDA Link 06/2013 - 11/2002
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 12/2004
2	N-Methylaspartate (NMDA)IBA 07/2012 - 01/2010
2	ElementsIBA 06/2012 - 07/2009
2	Exenatide (Byetta)FDA Link 01/2012 - 03/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 05/2011 - 02/2006
2	CurcuminIBA 01/2011 - 08/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2011 - 04/2006
2	PhysostigmineIBA 07/2010 - 02/2005
2	Chelating AgentsIBA 07/2009 - 11/2002
2	Blood Glucose (Blood Sugar)IBA 01/2009 - 06/2003
2	ZincIBA 12/2008 - 08/2004
2	CarbamatesIBA 01/2007 - 02/2005
2	Complement System Proteins (Complement)IBA 12/2004 - 11/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2004 - 12/2004
2	Thalidomide (Thalomid)FDA Link 01/2004 - 11/2003
1	IncretinsIBA 03/2024
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2024
1	Monoclonal AntibodiesIBA 03/2024

Therapy/Procedure

10	Therapeutics 12/2023 - 01/2002
2	Oral Administration 03/2024 - 12/2023
1	Drug Therapy (Chemotherapy) 03/2024